We have entered into a collaboration with Institute of Molecular and Cell Biology to discover and develop next-generation nucleic acid […]
We acquired the rights to develop promising HDAC inhibitors for AI-powered cancer drug development. Read more in our press release: […]
An application of our technology was recently featured in The Straits Times. You can read more about it here: https://www.straitstimes.com/singapore/ai-platform-aids-treatment-for-relapsed-lymphoma.
KYAN Therapeutics, in partnership with Powbab, a superfood company for better health, has developed an optimized health supplement to help […]